Abstract:Abstract Aim: 5-FU chemoresistance is a major challenge in gastric cancer patient's post-operation treatment. CMPK1 is a key metabolism enzyme associated with 5-FU phosphorylation activation, which is also functioned by epigenetic regulation-microRNA. We characterized the role of CMPK1 and potential regulated target-miR-193a in 5-FU chemotherapy response in gastric cancers. Methods: The roles of miR-193a on prognosis were assessed in a cohort of gastric cancer samples (n=90, tested by microarray assay) and reconfirmed in expanded samples (n=385, tested by q-PCR assay) with Kaplan-Meier and log-rank analysis. We used luciferase and Western-blot assays to test the regulation effect of miR-193a on CMPK1, and in vitro experiments including comet assay and 3-D spheroid assays to study whether miR-193a is associated with 5-FU chemoresistance. All statistical tests were two-sided. Results: MiR-193a high expression was associated with worse response to therapy and shorter progression-free survival in two cohorts (PFS: Primary microarray samples: [HR] = 1.28, 95% CI= 1.04 to 1.67, P = 0.005; Expanded samples: [HR] =1.08, 95% CI = 1.00 to 1.17, P = 0.050). In the expanded samples, patients received 5-FU-based therapeutic regimen which have high miR-193a expression was more likely to relapse (PFS<24 months VS PFS>60 months: 0.38±1.17 VS -0.89±1.41,p=0.001;2460 months: -0.20±1.59 VS -0.89±1.41,p=0.021 ). Comet assay showed that knock-down of CMPK1 impeded 5-FU caused DNA damage, induced a diminished cell cycle arrest and cell apoptosis. MiR-193a bound directly to the 3'-UTR of CMPK1 and downregulated CMPK1 expression in gastric cancer cells, showed parallel results about 5-FU sensitivity alike to CMPK1. Spheroid assays indicated that miR-193a-mediated attenuation of CMPK1 resulted in significant resistance of gastric cancer cells to 5-FU caused DNA damage and cell death (mean diameters of cell clones ± SD, miR-NC plus 5-FU vs miR-193a plus 5-FU: 78.5±14.8 VS 124.5±16.3, P<0.001; miR-NC plus 5-FU vs si-CMPK1 plus 5-FU: 78.5±14.8 VS 116.0±18.4, P=0.002 ), but not in cisplatin treatment (miR-NC plus 5-FU vs miR-193a plus 5-FU: 75.1±11.3 VS 82.2±12.7, P=0.274; miR-NC plus 5-FU vs si-CMPK1 plus 5-FU: 75.1±11.3 VS 82.0±17.4, P=0.316). Rescue experiments with augmented CMPK1 expression abolished the effect of miR-193a demonstrating the key function of this miRNA in this pathway. Conclusions: The discovery of a miR-193a-CMPK1-5-FU damage axis supports the methods that combining low miR-193a expression with 5-FU agents may substantially benefit gastric cancer management. MiR-193a might be a valuable predictive biomarker for the chemotherapy response in gastric cancer patients, and provided a therapeutic drug proposal for neoadjuvant chemotherapy. Citation Format: Hao Chen, Wei Wang, Ben Liu, Lu Han, Xinlei Chu, Hong Zheng, Yanrui Zhao, Xiangchun Li, Lian li, Fengju Song, Wei Zhang, Kexin Chen. Elevated miR-193a attenuates 5-fluorouricil metabolism enzyme CMPK1, resulting in therapeutic resistance and poor survival in gastric cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018; 2018 Apr 14-18; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 4412.

Abstract 5872: CDK1-SOX9 axis contributes to chemotherapy resistance in gastric cancer

Abstract 4412: Elevated Mir-193A Attenuates 5-Fluorouricil Metabolism Enzyme CMPK1, Resulting in Therapeutic Resistance and Poor Survival in Gastric Cancer

Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients

CDK5 promotes apoptosis and attenuates chemoresistance in gastric cancer via E2F1 signaling

Abstract 5075: Transcriptomic landscape of tumor microenvironment in gastric cancer in treatment with different types of cancer drugs

Abstract P43: Optimization of DNA Methyltransferase Inhibitors-based Combination to Target the Epigenome of Gastric Cancer

Abstract 3806: Integrative Omics Analysis in Gastric Cancer Reveals SLC7A5 Functional Related to DNA Mismatch Repair System As a Potential Therapeutic Biomarker in GC

Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44(+)/Musashi-1(+) gastric cancer stem cells

A CGA/EGFR/GATA2 positive feedback circuit confers chemoresistance in gastric cancer

The APEX1/miRNA-27a-5p axis plays key roles in progression, metastasis and targeted chemotherapy of gastric cancer

GM-CSF-miRNA-Jak2/Stat3 Signaling Mediates Chemotherapy-Induced Cancer Cell Stemness in Gastric Cancer

A combined analysis of bulk and single-cell sequencing data reveals that depleted extracellular matrix and enhanced immune processes co-contribute to fluorouracil beneficial responses in gastric cancer

Inhibition of CCCTC Binding Factor-Programmed Cell Death Ligand 1 Axis Suppresses Emergence of Chemoresistance Induced by Gastric Cancer-Derived Mesenchymal Stem Cells.

Molecular analysis of gastric cancer identifies genomic markers of drug sensitivity in Asian gastric cancer.

Gastric cancer derived mesenchymal stem cells promoted DNA repair and cisplatin resistance through up-regulating PD-L1/Rad51 in gastric cancer

Abstract 3237: KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer

WNT2–SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer

Abstract 3108: Preclinical studies of chemotherapies and targeted therapies to address gastric cancer disparities

Ott_a_276168 623..636

Abstract 6200: Single-cell analyses unravel novel immune and tumor cell characteristics linked to the response to neoadjuvant immune checkpoint blockade in patients with gastric cancer

Decitabine and Cisplatin Are Synergistic to Exert Anti-Tumor Effect on Gastric Cancer Via Inducing Sox2 DNA Demethylation